Yang, Lizhu
Fujinami, Kaoru
Ueno, Shinji
Kuniyoshi, Kazuki
Hayashi, Takaaki
Kondo, Mineo
Mizota, Atsushi
Naoi, Nobuhisa
Shinoda, Kei
Kameya, Shuhei
Fujinami-Yokokawa, Yu
Liu, Xiao
Arno, Gavin
Pontikos, Nikolas
Kominami, Taro
Terasaki, Hiroko
Sakuramoto, Hiroyuki
Katagiri, Satoshi http://orcid.org/0000-0001-7787-8194
Mizobuchi, Kei
Nakamura, Natsuko
Mawatari, Go
Kurihara, Toshihide http://orcid.org/0000-0002-5457-2720
Tsubota, Kazuo http://orcid.org/0000-0002-8874-7111
Miyake, Yozo
Yoshitake, Kazutoshi
Iwata, Takeshi
Tsunoda, Kazushige
Nishimura, Toshihide
Hayashizaki, Yoshihide
Shimozawa, Nobuhiro
Horiguchi, Masayuki
Yamamoto, Shuichi
Kuze, Manami
Machida, Shigeki
Shimada, Yoshiaki
Nakamura, Makoto
Fujikado, Takashi
Hotta, Yoshihiro
Takahashi, Masayo
Mochizuki, Kiyofumi
Murakami, Akira
Kondo, Hiroyuki
Ishida, Susumu
Nakazawa, Mitsuru
Hatase, Tetsuhisa
Matsunaga, Tatsuo
Maeda, Akiko
Noda, Kosuke
Tanikawa, Atsuhiro
Yamamoto, Syuji
Yamamoto, Hiroyuki
Araie, Makoto
Aihara, Makoto
Nakazawa, Toru
Sekiryu, Tetsuju
Kashiwagi, Kenji
Kosaki, Kenjiro
Piero, Carninci
Fukuchi, Takeo
Hayashi, Atsushi
Hosono, Katsuhiro
Mori, Keisuke
Tanaka, Kouji
Furuya, Koichi
Suzuki, Keiichirou
Kohata, Ryo
Yanagi, Yasuo
Minegishi, Yuriko
Iejima, Daisuke
Suga, Akiko
Rossmiller, Brian P.
Pan, Yang
Oshima, Tomoko
Nakayama, Mao
Yamamoto, Megumi
Minematsu, Naoko
Mori, Daisuke
Kijima, Yusuke
Kurata, Kentaro
Yamada, Norihiro
Itoh, Masayoshi
Kawaji, Hideya
Murakawa, Yasuhiro
,
Article History
Received: 29 April 2019
Accepted: 4 March 2020
First Online: 26 March 2020
Competing interests
: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor but may receive salary or other support from the institution to support their effort on the project(s). Kaoru Fujinami is a paid consultant of Astellas Pharma Inc, Kubota Pharmaceutical Holdings Co., Ltd, Acucela Inc., Novartis AG., NightstaRx Limited, and Sanofi Genzyme. Kaoru Fujinami reports personal fees from Astellas Pharma Inc, personal fees from Kubota Pharmaceutical Holdings Co., Ltd., personal fees from Acucela Inc., personal fees from Novartis AG., personal fees from SANTEN Company Limited, personal fees from Foundation Fighting Blindness, personal fees from Foundation Fighting Blindness Clinical Research Institute, and personal fees from Japanese Ophthalmology Society, personal fees from Japan Retinitis Pigmentosa Society. The laboratory of Visual Physiology, Division for Vision Research, National Institute of Sensory Organs, National Hospital Organization, Tokyo Medical Center, Tokyo, Japan is supported by grants from Astellas Pharma Inc. (NCT03281005), outside the submitted work. Toshihide Kurihara reports personal fees from Novartis Pharmaceuticals Japan, and Bayer Yakuhin, Ltd., outside the submitted work.